Latest News and Press Releases
Want to stay updated on the latest news?
-
Fleming Island, Florida, July 20, 2021 (GLOBE NEWSWIRE) -- Everything Blockchain, Inc., (OTCMKTS: OBTX), an advanced software architecture, development and services company specializing in...
-
Fleming Island, Florida, July 15, 2021 (GLOBE NEWSWIRE) -- Everything Blockchain (OTC: OBTX), an advanced software architecture, development and services company specializing in blockchain...
-
Fleming Island, Florida, July 12, 2021 (GLOBE NEWSWIRE) -- Everything Blockchain, Inc., (OTCMKTS: OBTX), an advanced software architecture, development and services company specializing in...
-
Fleming Island, Florida, June 29, 2021 (GLOBE NEWSWIRE) -- Everything Blockchain, Inc., (OTCMKTS: OBTX), an advanced software development and services company specializing in blockchain technologies...
-
Fleming Island, Florida, June 21, 2021 (GLOBE NEWSWIRE) -- Everything Blockchain, Inc., (OTCMKTS: OBTX), an advanced software development and services company specializing in blockchain technologies...
-
Fleming Island, Florida, June 14, 2021 (GLOBE NEWSWIRE) -- Everything Blockchain, Inc., (OTCMKTS: OBTX), an advanced software development, engineering, and services company specializing in...
-
Fleming Island, Florida, June 07, 2021 (GLOBE NEWSWIRE) -- EVERYTHING BLOCKCHAIN, INC. (OTC Markets: OBTX) today announces earning for May 2021. During the month of May 2021, which represents the...
-
Fleming Island, June 03, 2021 (GLOBE NEWSWIRE) -- Everything Blockchain, Inc., (formerly known as OBITX, Inc., OTCMKTS: OBTX), an advanced development, engineering, and services company specializing...
-
Fleming Island, Florida, May 26, 2021 (GLOBE NEWSWIRE) -- Profit and Loss: Revenue Grew by $1.1 Million from the Quarter Ended April 30, 2020 as compared to the Quarter Ended April 30, 2021.GAAP...
-
Jacksonville, FL, May 24, 2021 (GLOBE NEWSWIRE) -- Focusing on its blockchain and decentralized processing business acumen, OBITX, Inc., rebrands their company name and image. OBITX, INC. (OTC...